Eleva GmbH

https://www.elevabiologics.com

Eleva is a clinical-stage biopharmaceutical company unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform. The company’s proprietary drug development activities currently focus on complement disorders and enzyme replacement therapies. Factor H (CPV-104), a recombinant version of human complement Factor H, is expected to enter clinical studies in C3 Glomerulopathy (C3G) in H1 2025. The company’s aGal (RPV-001) program to treat Fabry disease has completed a Phase 1b clinical study with promising results. All programs are sourced from Eleva’s transformative moss-based expression system, which allows lab to GMP-scale manufacturing of challenging proteins with previously untapped therapeutic potential. *

	Start	2020-05-19 renamed
	Predecessor	Greenovation Biotech GmbH
	Industry	BIOTECH
	Industry 2	BryoMaster™ moss expression system
	Person	Schaaf, Andreas (Greenovation Biotech 201911– Managing Director)
	Person 2	Ronde, Jörg A. (Greenovation Biotech 201908– Managing Director)

	Region	Freiburg im Breisgau
	Country	Germany
	Street	19 Hans-Bunte-Str.
	City	79018 Freiburg
	Tel	+49-761-47099-0
		Address record changed: 2024-09-25

Basic data	Employees	B: 11 to 50 (2012-08-30)

		* Document for »About Section«: Eleva GmbH. (9/19/24). "Press Release: Eleva Appoints Dr. Elisabeth Lackner to Its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization". Freiburg im Breisgau.

		Record changed: 2025-03-16

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Eleva GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)